Last reviewed · How we verify
NCT07079189
Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on Glycemic Control in Patients With Type 2 Diabetes.
NA trial testing Lifestyle tool in Diabetes Mellitus (Type 2) in 300 participants. Currently enrolling.
31 May 2027
Quick facts
| Lead sponsor | Region Skane |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 11 August 2025 |
| Primary completion | 31 May 2027 |
| Estimated completion | 1 December 2027 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Lifestyle tool
Conditions studied
- Diabetes Mellitus (Type 2) — all drugs for Diabetes Mellitus (Type 2) →
Sponsor
Region Skane — full company profile →
Who can join
35 and older, any sex, with Diabetes Mellitus (Type 2). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall aim of the study is to observe the change of long-term metabolic control in patients with type 2 diabetes who have access to a digital intervention tool as compared with randomized controls during one year. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07079189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lifestyle tool
Trials testing the same drug.
- NCT05679115 — Evaluation of Lifestyle Tool in Type 2 Diabetes · NA · active not recruiting
- NCT05309876 — Secondary Prevention With the Lifestyle Tool · NA · recruiting
- NCT05309850 — Primary Prevention With the Lifestyle Tool · NA · recruiting
- NCT05006508 — Prevention With the Health and Lifestyle Tool · NA · active not recruiting
Other recruiting trials for Diabetes Mellitus (Type 2)
Currently open trials in the same condition.
- NCT05169359 — Empowering Veterans to Actively Communicate and Engage in Shared Decision Making in Medical Visits, A Randomized Control · NA · active not recruiting
Other Region Skane trials
Trials by the same sponsor.
- NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
- NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
- NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
- NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
- NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07079189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Skane
- Last refreshed: 14 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07079189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing